Profile: Guided Therapeutics, Inc. specializes in the development of LightTouch™ rapid and painless test for the early detection of neoplasia of the cervix. It is designed as a non-invasive test that has the potential to significantly improve the early detection of cervical precancers and cancers. Our LightTouch™ uses proprietary technology to identify cancers and precancers quickly by analyzing light reflected from the cervix. It creates an image of the cervix for the doctor that highlights the location and severity of disease. The technology distinguishes between normal and diseased tissue by detecting biochemical & morphological changes at the cellular level. The LightTouch™ device uses light to detect chemical and structural changes in cervical tissue. A broad array of light frequencies is shown on the cervix. Light that is returned from the cervix is analyzed by a spectrometer. The LightTouch™ non-invasive cervical cancer analyzer uses light to detect both physical and chemical changes in tissue that may be markers of cervical disease.

The company was founded in 1992, has revenues of < USD 1 Million, has ~20 employees and is ISO 9001, CE Mark certified. OTC:SPRX (SEC Filings)

FDA Registration Number: 3003385435